Literature DB >> 16738844

Two cases with pachydermoperiostosis and discussion of tamoxifen citrate treatment for arthralgia.

Aysenur Okten1, Ilke Mungan, Mukaddes Kalyoncu, Zerrin Orbak.   

Abstract

Idiopathic hypertrophic osteoarthropathy is a rare syndrome, characterized by clubbing, progressive enlargement of the joints, coarse facial features suggesting acromegaly, palmoplantar hyperhidrosis, fibrous covering at the ends of long bones (periostosis), and acro-osteolysis. It is a self-limiting condition but arthralgia may be as severe as limiting social life and activity, and it is the main complaint to be treated. We report on two siblings with pachydermoperiostosis (PDP), one of whom had arthralgia. Although several drugs have been used, we used tamoxifen for his arthralgia and his complaint disappeared. To the best of our knowledge, this is the second case treated by tamoxifen reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16738844     DOI: 10.1007/s10067-005-1161-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Successful treatment of arthralgia with tamoxifen citrate in a patient with pachydermoperiostosis.

Authors:  H Maeda; K Kumagai; F Konishi; Y Katayama; K Hiyama; S Ishioka; M Yamakido
Journal:  Rheumatology (Oxford)       Date:  2000-10       Impact factor: 7.580

2.  CLUBBING, A REVIEW, WITH EMPHASIS ON HEREDITARY ACROPACHY.

Authors:  D S FISCHER; D H SINGER; S M FELDMAN
Journal:  Medicine (Baltimore)       Date:  1964-07       Impact factor: 1.889

3.  PACHYDERMOPERIOSTOSIS (IDIOPATHIC CLUBBING AND PERIOSTOSIS): GENETIC AND PHYSIOLOGIC CONSIDERATIONS.

Authors:  D L RIMOIN
Journal:  N Engl J Med       Date:  1965-05-06       Impact factor: 91.245

4.  The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy).

Authors:  M Matucci-Cerinic; T Lotti; I Jajic; A Pignone; C Bussani; M Cagnoni
Journal:  Medicine (Baltimore)       Date:  1991-05       Impact factor: 1.889

5.  Hypertrophic osteoarthropathy in the paediatric age.

Authors:  B M Ansell
Journal:  Clin Exp Rheumatol       Date:  1992 May-Jun       Impact factor: 4.473

6.  Pachydermoperiostosis (primary hypertrophic osteoarthropathy): in vitro evidence for abnormal fibroblast proliferation.

Authors:  M Matucci-Cerinic; L Sacerdoti; C Perrone; A Carossino; M L Cagnoni; I Jajic; T Lotti
Journal:  Clin Exp Rheumatol       Date:  1992 May-Jun       Impact factor: 4.473

7.  Pachydermoperiostosis: analysis of the connective tissue abnormality in one family.

Authors:  A Oikarinen; R Palatsi; M Kylmäniemi; J Keski-Oja; J Risteli; M Kallioinen
Journal:  J Am Acad Dermatol       Date:  1994-12       Impact factor: 11.527

8.  The spectrum of soft tissue and skeletal abnormalities of hypertrophic osteoarthropathy.

Authors:  C Pineda; C Fonseca; M Martinez-Lavin
Journal:  J Rheumatol       Date:  1990-05       Impact factor: 4.666

9.  Pachydermoperiostosis: study of epidermal growth factor and steroid receptors.

Authors:  L Bianchi; C Lubrano; A M Carrozzo; S Iraci; M Tomassoli; G Spera; G Nini
Journal:  Br J Dermatol       Date:  1995-01       Impact factor: 9.302

Review 10.  [Pachydermoperiostosis--report of a case and review of 121 Japanese cases].

Authors:  Y Matsui; Y Nishii; M Maeda; N Okada; K Yoshikawa
Journal:  Nihon Hifuka Gakkai Zasshi       Date:  1991-03
View more
  7 in total

Review 1.  Acro-osteolysis.

Authors:  Anna Botou; Athanasios Bangeas; Ioannis Alexiou; Lazaros I Sakkas
Journal:  Clin Rheumatol       Date:  2016-10-29       Impact factor: 2.980

2.  Pachydermoperiostosis-critical analysis with report of five unusual cases.

Authors:  Anna Latos-Bielenska; Ivo Marik; Miroslaw Kuklik; Anna Materna-Kiryluk; Czeslaw Povysil; Kazimierz Kozlowski
Journal:  Eur J Pediatr       Date:  2007-02-07       Impact factor: 3.183

3.  Prostaglandin E2 and bone turnover markers in the evaluation of primary hypertrophic osteoarthropathy (pachydermoperiostosis): a case report.

Authors:  A Martínez-Ferrer; P Peris; Ll Alós; M Morales-Ruiz; N Guañabens
Journal:  Clin Rheumatol       Date:  2009-05-21       Impact factor: 2.980

Review 4.  Cranio-osteoarthropathy: a rare variant of hypertrophic osteoarthropathy.

Authors:  X Chen; C C Zou; G P Dong; L Liang; Z Y Zhao
Journal:  Ir J Med Sci       Date:  2009-05-09       Impact factor: 1.568

5.  Gastric juvenile polyposis with high-grade dysplasia in pachydermoperiostosis.

Authors:  L de Mestier; S Moreau; C Neuzillet; P Ruszniewski; Y Panis; P Hammel
Journal:  Case Rep Gastroenterol       Date:  2011-09-03

6.  The first case of primary hypertrophic osteoarthropathy with soft tissue giant tumors caused by HPGD loss-of-function mutation.

Authors:  Qianqian Pang; Yuping Xu; Xuan Qi; Yan Jiang; Ou Wang; Mei Li; Xiaoping Xing; Ling Qin; Weibo Xia
Journal:  Endocr Connect       Date:  2019-06       Impact factor: 3.335

7.  Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: A single-arm intervention trial.

Authors:  Lu Yuan; Ruo-Xi Liao; Yuan-Yuan Lin; Yan Jiang; Ou Wang; Mei Li; Xiao-Ping Xing; Qian-Qian Pang; Evelyn Hsieh; Wei-Bo Xia
Journal:  J Orthop Translat       Date:  2018-10-31       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.